Document is current
Any future updates will be listed below
-
Authors
Tarannum, Sanjana http://orcid.org/0000-0003-0576-6278
Leung, Ying-Ying http://orcid.org/0000-0001-8492-6342
Johnson, Sindhu R. http://orcid.org/0000-0003-0591-2976
Widdifield, Jessica http://orcid.org/0000-0002-7464-0460
Strand, Vibeke http://orcid.org/0000-0003-4978-4072
Rochon, Paula
Eder, Lihi http://orcid.org/0000-0002-1473-1715
- License Information
-
More Information
Article History
Accepted: 29 June 2022
First Online: 4 August 2022
Competing interests
: Y.-Y.L. received an honorarium from AbbVie, DKSH, Janssen, Novartis and Pfizer. V.S. has received consultation fees from AbbVie, Amgen Corporation, Arena, Aria, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, Galapagos, Genentech/Roche, Gilead, GSK, Horizon, Ichnos, Janssen, Lilly, Merck, Novartis, Pfizer, Regeneron, Rheos, Samsung, Sandoz, Sanofi, Sorrento, Sun Pharma, and UCB. L.E. received educational and research grants and consultation fees from AbbVie, UCB, Eli Lily, Novartis, Sandoz and Pfizer. S.R.J., J.W., S.T. and P.R. declare no competing interests.
